mitozolomide has been researched along with Ovarian Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, TH; Damian, Z; De Marte, J; Jean-Claude, BJ; Leyland-Jones, B; Mustafa, A; Vasilescu, DE; Yen, R | 1 |
| Docherty, V; Dorward, A; Harding, M; Kaye, S; Mackie, R | 1 |
| Carnino, F; George, M; Guastalla, JP; Neijt, JP; Piccart, M; Rotmensz, N; van der Burg, ME; Vermorken, J | 1 |
| Green, JA; Harding, M; Newlands, E; Northcott, D; Smyth, J; Stuart, NS | 1 |
| D'Incalci, M; Erba, E; Landoni, F; Lorico, A; Mangioni, C; Morasca, L; Pepe, S; Ubezio, P | 1 |
5 other study(ies) available for mitozolomide and Ovarian Neoplasms
| Article | Year |
|---|---|
Comparative studies between the effects of mitozolomide and two novel tetrazepinones PYRCL and QUINCL on NIH:OVCAR-3 cells.
Topics: Alkylation; Antineoplastic Agents; Azepines; Cell Cycle; DNA; DNA Damage; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Guanine; Humans; Nitrogen Mustard Compounds; Ovarian Neoplasms; Pyridines; Quinolines; Tumor Cells, Cultured | 1998 |
Phase II studies of mitozolomide in melanoma, lung and ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Ovarian Neoplasms | 1989 |
Phase II trial of mitozolomide in patients with advanced ovarian cancer. A study of the EORTC Gynecological Cancer Cooperative Group.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Middle Aged; Nitrogen Mustard Compounds; Ovarian Neoplasms; Survival Rate | 1989 |
Phase II evaluation of mitozolomide in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nitrogen Mustard Compounds; Ovarian Neoplasms; Thrombocytopenia | 1988 |
Mitozolomide activity on human cancer cells in vitro.
Topics: Aged; Antineoplastic Agents; Carmustine; Cell Cycle; Cell Line; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Melanoma; Middle Aged; Mitosis; Nitrogen Mustard Compounds; Ovarian Neoplasms; Thymidine | 1986 |